Supernus Pharmaceuticals Profit Margin Quarterly:
-1241% for Dec. 31, 2012Supernus Pharmaceuticals Historical Profit Margin Quarterly Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -1241% |
| Sept. 30, 2012 | -14815% |
| June 30, 2012 | -11003% |
| March 31, 2012 | -4460% |
| Dec. 31, 2011 |
| Sept. 30, 2011 | -88491% |
| June 30, 2011 | -983.6% |
| March 31, 2011 | |
| Dec. 31, 2010 | |
| Dec. 31, 2009 | -237.5% |
About Profit Margin
Profit margin represents the percentage of revenue that a company keeps as profit after accounting for fixed and variable costs. It is calculated by dividing net income by revenue. The profit margin is mainly used for internal comparisons, because acceptable profit margins vary between industries. In general, narrow profit margins indicate increased volatile earnings. For companies with significant fixed costs, wide profit margins reduce the risk that a decline in sales will cause a net profit loss.
Displayed as a percentage, profit margin can be thought as the amount of profit that a company keeps per dollar of revenue. For example, if a company has a profit margin of 43%, the company keeps $.43 of each dollar of revenue.
Learn More
SUPN Profit Margin Quarterly Benchmarks
| Companies | |
|---|---|
| Catalyst Pharmaceutical Partners | |
| MEI Pharma | |
| Keryx Biopharmaceuticals |
SUPN Profit Margin Quarterly Rankings
| Overall |
37th percentile 4747 of 7593 |
| Sector |
29th percentile 457 of 650 in Healthcare |
| Industry |
32nd percentile 44 of 65 in Drug Manufacturers - Specialty & Generic |
SUPN Profit Margin Quarterly Range, Past 5 Years
| Minimum | -88491% | Sep 2011 |
| Maximum | -237.5% | Dec 2009 |
| Average | -17319% |
SUPN News
Street Insider May 17
